Unspecifically blocks respiratory viruses causing the common cold
Blocks allergens on the mucosal surface
Adds moisturizing film to mucosal surfaces
Currently, seven Carragelose-containing products for the prophylaxis and treatment of viral respiratory diseases have been marketed in wide parts of the world. For 2024, the launch of an allergen-blocking nasal spray and mositurizing eye drops is planned. In addition, a Carragelose inhalation solution is in development.
Carragelose forms a protective layer on mucosal surfaces that prevents viruses and allergens from interacting with the mucosal surface. Furthermore, it adds a moisturizing film that helps to keep the mucosa in the nasal cavity and in the throat resilient and as ophthalmic formulation, provides relief of dry eyes.
